STAT

Cochrane ousted researcher over improper use of letterhead, board co-chair says

The Cochrane Collaboration ousted a researcher because he repeatedly misused official letterhead to espouse personal views, the board co-chair says.

A physician and researcher recently kicked out of one of the world’s most authoritative medical research bodies repeatedly misused official letterhead to espouse personal views, the co-chair of the organization’s governing board told STAT and Retraction Watch.

The governing board of The Cochrane Collaboration, which reviews the scientific literature in areas of clinical research and produces widely cited analyses that help guide medical practice, earlier this month. Gøtzsche was the director of the , in Copenhagen, Denmark,

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

Related